consultancies
MARTIN FLEISCHER
Life science manager
University degree: Italian «Laurea» (comparable to bachelor) in chemistry from Milan University
Citizenship: German
Address: Italia – Via Beato Lodovico Pavoni, 4 – 25050 Provaglio d’Iseo (BS)
DOB: 14 May 1971
Mobile: +393409225430
E-mail: work@martin-fleischer.com
Languages: 
working experience
Timeline
February 2023
Freelance consultant
since spring 2019
Services to companies operating in the health care sector:
- set up and fine-tuning of procedures, with a focus on interception and compliance monitoring of transfers of value (ToV) to health care professionals (HCPs) and health care organizations (HCOs)
- decentralization of compliance monitoring by disaggregating legal requirements into independent checklists assigned to different roles within the company
- pre-softwarization audits and assessments
- small custom software solutions based on my CREATE platform
February 2018
HBO (Head of Business Operations) South Europe
Biotest, Via Leonardo da Vinci, 43 – 20090 Trezzano Sul Naviglio (MI)
(from 01/09/2017 to 06/02/2018 = 5 months)
In the TAs (Therapeutic Areas) «Organ Transplantation & Infectology»:
- management of 7 people with scientific and marketing tasks for the Southern Europe region, an area that spans several Mediterranean countries from Portugal to Israel
- management of B2B relationships (both with affiliates and external partner companies)
- development of strategies and tools for objective prioritization of medical projects
- “first time ever” for this German company: development of a bi-lingual contract with an Italian healthcare organization (HCO) to support a nonprofit study in Italy in light of law 17/12/2004 (IgM-FAT trial)
August 2017
Medical Manager
Biotest, Via Leonardo da Vinci, 43 – 20090 Trezzano Sul Naviglio (MI)
(from 01/07/2014 to 31/08/2017 = 3 years and 2 months)
In the TA (Therapeutic Areas) «Organ Transplantation & Infectology»:
usual spectrum of activities of a medical department
- training
- marketing support
- clinical trials support
- relationships with key opinion leaders (KOLs)
- ad-boards
Management of staff (2 MSL = Medical Scientific Liaison), with tasks like
- organization of HSMs (Hospital Staff Meetings) = in-hospital scientific meetings with health care professionals (HCPs)
- management of MQs (Medical Queries) = requests for information from health care professionals (HCPs)
- scientific support & training commercial field force
NOTE: to manage the newly founded medical department, I coded and set-up a GPS-assisted mobile CRM-system. This web application was mainly used to log Hospital Staff meetings (HSMs), FTF-visits with HCPs (Health Care Professionals) and to build a centralized repository of medical information provided by the company, required for quality assurance and pharmacovigilance
June 2014
Medical Manager
Swedish Orphan Biovitrum, Strada Quarta 6/1 D – 43123 Parma (PR)
(from 01/04/2013 to 30/06/2014 = 1 year and 3 months)
In the TAs (Therapeutic Areas) «inflammation/rheumatology»:
- preparation of the Italian pricing-dossier for the new, EMA-approved orphan indication of the Interleukin-1 receptor antagonist (IL-1Ra) KINERET® (anakinra), concerning the treatment of CAPS (Cryopyrin-Associated Periodic Syndrome), a rare autoinflammatory disorder
- support of Investigator Sponsored Trials (ISS) in accordance with Italian D.M. 17/12/2004 (AIR-TRIP, TRACK)
- development and continuous updating with the latest scientific publications of a literature database compatible with Mendeley®, Papership® and Endnote® citation managers
- organization of HSMs (Hospital Staff Meetings) = in-hospital scientific meetings with health care professionals (HCPs)
- management of MQs (Medical Queries) = requests for information from health care professionals (HCPs)
- collaboration with international task-forces
- marketing support for product strategy
- scientific support & training commercial field force
March 2013
Field Product Manager
Swedish Orphan International, Strada Quarta 6/1 D – 43123 Parma (PR)
(from 23/02/2009 to 31/03/2013 = 4 years and one month)
In the TA (Therapeutic Area) «inflammation/rheumatology»:
Marketing strategy development (and implementation in collaboration with international business partners) for the brand KINERET™ (anakinra), a recombinant human Interleukin-1 receptor antagonist (IL-1Ra), initially approved for the treatment of Rheumatoid arthritis, but due to its striking effectiveness also frequently used off-label for the treatment of IL-1 mediated, autoinflammatory diseases, such as CAPS (Cryopyrin-Associated Periodic Syndrome); TRAPS (Tumor Necrosis Factor Receptor Associated Periodic Syndrome); SJIA (Systemic Juvenile Idiopathic Arthritis); AoSD (Adult onset Still’s Disease) – KINERET™ (anakinra) later gathered approval for the treatment of some these disorders
February 2009
Product Specialist
sanofi-aventis, Viale Luigi Bodio, 37/b – 20158 Milano (MI)
(from 01/01/2007 to 19/02/2009 = 2 years and 2 months)
In the TA (Therapeutic Area) «oncology»:
product specialist in 3 provinces of Northern Italy (Brescia, Trento and Bolzano, because of my native language) for the brand TAXOTERE™ (docetaxel), an antineoplastic drug (cancer drug) approved and used for the treatment of a variety of solid tumors; my task was to provide information regarding its use in the treatment of early and advanced breast cancer to Health Care Professionals (HCPs); during this activity:
- organization of HSMs (Hospital Staff Meetings) = in-hospital scientific meetings with health care professionals (HCPs)
- development and partial writing in cooperation with an oncologist of a pocket guide on the systemic treatment of early-stage breast cancer («Il Taccuino Blu» [in Italian])
December 2006
Product Manager
sanofi-aventis, Viale Luigi Bodio, 37/b – 20158 Milano (MI)
(from 01/01/2005 to 31/12/2006 = 2 years)
In the TA (Therapeutic Area) «oncology»:
- marketing strategy development (and tactical implementation) for the brand ELOXATIN™ (oxaliplatin), an antineoplastic drug (anti-cancer medicine) used for the treatment of colorectal cancer (approved indication) and other types of gastrointestinal cancers
- post-patent strategy for the brand name ELOXATIN™ (oxaliplatin)
- indication management of TAXOTERE™ (docetaxel) for the treatment of advanced gastric cancer
December 2004
Product Specialist
Sanofi-Synthélabo, Via Messina, 38 – 20154 Milano (MI)
(from 01/04/2003 to 31/12/2004 = 2 years and 9 months)
In the TA (Therapeutic Area) «oncology»:
product specialist in 3 provinces in Northern Italy (Brescia, Trento and Bolzano, due to my mother tongue) for the brand ELOXATIN™ (oxaliplatin), an antineoplastic drug (anti-cancer medicine) used for the treatment of colorectal cancer (approved indication) and other types of gastrointestinal cancers
March 2003
Sales Rep (pharma)
Sanofi-Synthélabo, Via Messina, 38 – 20154 Milano (MI)
(from 18/03/2002 to 31/03/2003 = 1 year)
In the TA (Therapeutic Area) «cardiology, urology»:
Sales Rep in the Province of Brescia (Northern Italy)
March 2002
Sales Rep (pharma)
Malesci, Via Lungo L’Ema, 7 – 50012 Bagno a Ripoli (FI)
(from 05/03/2001 to 15/03/2002 = 1 year)
In the TA (Therapeutic Area) «general practitioner»:
Sales Rep in the Province of Brescia (Northern Italy)
Given the corporate demand for high «average daily office visits» I had developed my own CRM that optimized routes, taking into account also availability of general practitioners in peripheral medical offices
Generic skills
Technical skills
legal & regulatory aspects of support for clinical trials
pharmaceutical business & marketing
compliance, application of laws & ethics codes
literature management & use of citation managers
database-design and administration
coding in VBA/VBScript, php, javascript, use of mySQL
design and softwarization of complex procedures
clinical trial design and management
medical writing
regulatory dossier writing
Past Projects
CREATE
The «goFARbot»
Project «goFAR»
“Transparency project”
ASK (Anakinra Survival Kit)
«Il Taccuino Blu»
What people say about me
Go ahead – contact me:
* compulsory fields
